Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Prader-Willi Syndrome
NCT02810483Phase 3Terminated
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Dec 2012
- Primary completion
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of topiramate in Prader-Willi syndrome (PWS), sponsored by Assistance publique - Hôpitaux de Paris. Started Dec 2012; status: terminated.
02
Drugs
topiramate
03
Conditions
Prader-Willi syndrome (PWS)
Beyond the preview
Go deeper on NCT02810483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02810483.